The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is 31.78 USD. With the latest stock price at 21.85 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is 45.4%.
Based on the latest price of 21.85 USD and our DCF valuation, ACADIA Pharmaceuticals Inc (ACAD) is a buy. buying Acadia stocks now will result in a potential gain of 45.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 10.0% | 8.9% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 25.40 - 43.57 | 31.78 |
| Upside | 16.3% - 99.4% | 45.4% |